{"product_id":"cancer-consult-expertise-in-clinical-practice-volume-2-neoplastic-hematology-cellular-therapy","title":"Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology \u0026 Cellular Therapy","description":"\u003cdiv data-cel-widget=\"bookDescription_feature_div\" data-csa-c-id=\"7y9w7h-rgk3d4-2xixgp-6jetc1\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-asin=\"0993745598\" data-csa-c-slot-id=\"bookDescription_feature_div\" data-csa-c-content-id=\"bookDescription\" data-csa-c-type=\"widget\" data-feature-name=\"bookDescription\" class=\"celwidget\" id=\"bookDescription_feature_div\"\u003e\n\u003cdiv class=\"a-expander-collapsed-height a-row a-expander-container a-spacing-base a-expander-partial-collapse-container\" data-a-expander-collapsed-height=\"280\" data-a-expander-name=\"book_description_expander\"\u003e\n\u003cdiv class=\"a-expander-content a-expander-partial-collapse-content\" aria-expanded=\"false\"\u003e\n\u003cp\u003e\u003cspan class=\"a-text-bold\"\u003eNew edition covering the specialties of hematology, oncology and cellular therapy, now in two volumes\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"a-text-italic\"\u003eCancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology \u0026amp; Cellular Therapy, Second Edition\u003c\/span\u003e\u003cspan\u003e includes hundreds of answers to practice-based questions covering the new principles of diagnosis, classification, staging, treatment, and outcomes in the rapidly advancing field of cancer. This textbook series also provides expert guidance in the areas of cancer-related uncertainties and controversies, including experience-based discussions. The book’s smaller size allows for easy access during medical rounds. This volume also includes:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul class=\"a-unordered-list a-vertical\"\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan\u003eUp-to-date clinically relevant information on the very latest topics such as molecular techniques, targeted therapies, immunotherapy, BMT, CAR T-cell therapy and translational cancer research\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan\u003eSections on ALL, AML, myeloid neoplasms, CLL, Hodgkin’s and Non-Hodgkin’s lymphomas, amongst other topics\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan\u003eStreamlined, engaging content to make finding information easier and less time consuming for the reader\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan\u003eConcise and practical expert perspectives that reference key studies\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan\u003eReferences to the latest NCCN, ESMO, ASH, ASTCT, EBMT and other national guidelines\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eWith its powerful focus on pragmatic clinical diagnostic, therapeutic and prognostic approaches, \u003c\/span\u003e\u003cspan class=\"a-text-italic\"\u003eCancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology \u0026amp; Cellular Therapy, Second Edition\u003c\/span\u003e\u003cspan\u003e will help keep hematology, oncology and cellular therapy practitioners up-to-date, bridging the gaps between journal and reference literature, conferences, and their existing knowledge base. It also offers clinicians, trainees, and fellows an excellent opportunity to enhance their preparation for the ABIM, hematology and oncology fellowship and recertification exams.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv data-cel-widget=\"globalStoreInfoBullets_feature_div\" data-csa-c-id=\"5xdo1d-34cqab-44okim-umrqji\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-asin=\"0993745598\" data-csa-c-slot-id=\"globalStoreInfoBullets_feature_div\" data-csa-c-content-id=\"globalStoreInfoBullets\" data-csa-c-type=\"widget\" data-feature-name=\"globalStoreInfoBullets\" class=\"celwidget\" id=\"globalStoreInfoBullets_feature_div\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv data-cel-widget=\"buyingOptionNostosBadge_feature_div\" data-csa-c-id=\"m88roa-uy5w9v-hk45c0-79y2qx\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-asin=\"0993745598\" data-csa-c-slot-id=\"buyingOptionNostosBadge_feature_div\" data-csa-c-content-id=\"buyingOptionNostosBadge\" data-csa-c-type=\"widget\" data-feature-name=\"buyingOptionNostosBadge\" class=\"celwidget\" id=\"buyingOptionNostosBadge_feature_div\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv data-cel-widget=\"tellAmazon_feature_div\" data-csa-c-id=\"vdlf86-wzc9x7-s2ji6f-qr08be\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-asin=\"0993745598\" data-csa-c-slot-id=\"tellAmazon_feature_div\" data-csa-c-content-id=\"tellAmazon\" data-csa-c-type=\"widget\" data-feature-name=\"tellAmazon\" class=\"celwidget\" id=\"tellAmazon_feature_div\"\u003e\n\u003cdiv data-cel-widget=\"tell-amazon-desktop_DetailPage_6\" data-csa-c-id=\"cjjm8i-e0er5q-92apu-3dgwhw\" data-csa-c-painter=\"tell-amazon-desktop-cards\" data-csa-c-type=\"widget\" data-csa-c-slot-id=\"DsUnknown-7\" data-csa-c-content-id=\"DsUnknown\" data-csa-op-log-render=\"\" class=\"celwidget c-f\"\u003e\n\u003cdiv data-mix-claimed=\"true\" data-acp-tracking=\"{}\" data-card-metrics-id=\"tell-amazon-desktop_DetailPage_6\" id=\"CardInstancehEDeCVeDQg4d6_9fzillnQ\"\u003e\n\u003ch3\u003e\u003cspan\u003eBiografía del autor\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv class=\"a-section a-spacing-small a-padding-small\"\u003e\n\u003cp\u003e\u003cspan class=\"a-text-bold\"\u003eSyed A. Abutalib, MD,\u003c\/span\u003e\u003cspan\u003e is Co-Director of Hematology and Stem Cell Transplantation and Clinical Director of NMDP\u003c\/span\u003e\u003cspan\u003e\u003csup\u003e®\u003c\/sup\u003e\u003c\/span\u003e\u003cspan\u003e Apheresis Center at the Midwest Branch of Cancer Treatment Centers of America, (CTCA), Part of City of Hope.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"a-text-bold\"\u003eMaurie Markman, MD,\u003c\/span\u003e\u003cspan\u003e is President of Medicine \u0026amp; Science, Cancer Treatment Centers of America, Part of City of Hope.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"a-text-bold\"\u003eJames O. Armitage, MD,\u003c\/span\u003e\u003cspan\u003e is the Joe Shapiro Professor of Medicine at University of Nebraska Medical Center and has served as Dean for College of Medicine and Chairman of Internal Medicine. He is past President of both the ASCO and the ASTCT.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"a-text-bold\"\u003eKenneth C. Anderson, MD,\u003c\/span\u003e\u003cspan\u003e is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. He is past President of ASH.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv data-cel-widget=\"richProductInformation_feature_div\" data-csa-c-id=\"n6t0gk-989hvp-s3iwgg-tuyjq8\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-asin=\"0993745598\" data-csa-c-slot-id=\"richProductInformation_feature_div\" data-csa-c-content-id=\"richProductInformation\" data-csa-c-type=\"widget\" data-feature-name=\"richProductInformation\" class=\"celwidget\" id=\"richProductInformation_feature_div\"\u003e\n\u003cdiv data-cel-widget=\"rich_product_information\" data-csa-c-id=\"v0i3b3-rqfhzk-ixt9xs-9wgk53\" class=\"a-section a-spacing-none celwidget\" id=\"rich_product_information\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv data-csa-c-id=\"e48qwb-36wm3s-vb6e8j-pnxs9b\" data-cel-widget=\"aplus-module-12\" class=\"celwidget aplus-module module-12 aplus-standard\"\u003e\n\u003cdiv class=\"aplus-module-wrapper apm-spacing apm-floatnone apm-fixed-width\"\u003e\n\u003cdiv class=\"apm-sidemodule aplus-module-content\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"a-section a-spacing-small a-padding-base\"\u003e\n\u003cdiv class=\"section-title collapsed\" data-toggle=\"collapse\"\u003eTable of Contents\u003c\/div\u003e\n\u003cdiv class=\"section-content collapsed\"\u003e\n\u003cp\u003eEditors Volume 2 xii\u003c\/p\u003e\n\u003cp\u003ePreface xiii\u003c\/p\u003e\n\u003cp\u003eAuthor Bios xv\u003c\/p\u003e\n\u003cp\u003eAcknowledgement xvii\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eVolume 1: Solid Tumors \u0026amp; Supportive Care\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eVolume 1 Editors:\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eSyed A. Abutalib, Maurie Markman, Al B. Benson III, and Hope S. Rugo\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePart 1 Acute Lymphoblastic Leukemia in Adults 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e1 Prognostic Markers and Models in Acute Lymphoblastic Leukemia 3\u003cbr\u003e\u003ci\u003eDieter Hoelzer\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e2 Acute Lymphoblastic Leukemia—Treatment and Outcomes in B-ALL 11\u003cbr\u003e\u003ci\u003eVijaya Raj Bhatt, Prajwal Dhakal, and Syed A. Abutalib\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e3 T Cell Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma 27\u003cbr\u003e\u003ci\u003eSyed A. Abutalib and Daniel J. DeAngelo\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e4 Minimal Residual Disease in Acute Lymphoblastic Leukemia 51\u003cbr\u003e\u003ci\u003eCaner Saygin, Sarah Monick, and Wendy Stock\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e5 Hematopoietic Transplantation and Cellular Therapy in Acute Lymphoblastic Leukemia 63\u003cbr\u003e\u003ci\u003eYael Morgenstern, Netanel A. Horowitz, and Jacob M. Rowe\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePart 2 Acute Myeloid Leukemia in Adults 81\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e6 Prognosis in Acute Myeloid Leukemia: Beyond Cytogenetics 83\u003cbr\u003e\u003ci\u003eCaner Saygin and Lucy A. Godley\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e7 Young Adults with Acute Myeloid Leukemia 93\u003cbr\u003e\u003ci\u003eSangeetha Venugopal and Farhad Ravandi\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e8 Older Adults with Acute Myeloid Leukemia 103\u003cbr\u003e\u003ci\u003eMary-Elizabeth Percival and Elihu Estey\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e9 Acute Promyelocytic Leukemia 113\u003cbr\u003e\u003ci\u003eEytan M. Stein and Martin S. Tallman\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e10 Measurable Residual Disease in Acute Myeloid Leukemia 121\u003cbr\u003e\u003ci\u003eMarie Bill and Hans Beier Ommen\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e11 Hematopoietic Cell Transplantation and Cellular Therapy in Acute Myeloid Leukemia 133\u003cbr\u003e\u003ci\u003ePiyanuch Kongtim and Stefan O. Ciurea\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePart 3 Myelodysplastic Syndromes and Familial Myeloid Neoplasms 147\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e12 Diagnosis of Myelodysplastic Syndromes 149\u003cbr\u003e\u003ci\u003eJay Yang, Vijendra Singh, Ali Gabali, and Charles A. Schiffer\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e13 Treatment of Myelodysplastic Syndromes 165\u003cbr\u003e\u003ci\u003eRami S. Komrokji\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e14 Hematopoietic Cell Transplantation and Cellular Therapy in Myelodysplastic Syndromes 179\u003cbr\u003e\u003ci\u003eIbrahim Yakoub-Agha\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e15 Familial Myeloid Neoplasms—When to Suspect and What to Do? 191\u003cbr\u003e\u003ci\u003eRyan J. Stubbins, Amy M. Trottier , Simone Feurstein, and Lucy A. Godley\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePart 4 Myeloproliferative Neoplasms 211\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e16 Chronic Myeloid Leukemia: Chronic Phase Disease 213\u003cbr\u003e\u003ci\u003eJerald P. Radich\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e17 Chronic Myeloid Leukemia: Advance Phases of the Disease 221\u003cbr\u003e\u003ci\u003eMichael J. Mauro\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e18 Chronic Myeloid Leukemia: Treatment Safety During Reproductive Age and Pregnancy 229\u003cbr\u003e\u003ci\u003eMichael J. Mauro\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e19 Chronic Myeloid Leukemia: Cessation of Therapy 235\u003cbr\u003e\u003ci\u003eAnand A. Patel and Richard A. Larson\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e20 Hematopoietic Cell Transplantation in Chronic Myeloid Leukemia 243\u003cbr\u003e\u003ci\u003eJerald P. Radich\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e21 Polycythemia Vera 255\u003cbr\u003e\u003ci\u003ePrithviraj Bose and Srdan Verstovsek\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e22 Essential Thrombocythemia 265\u003cbr\u003e\u003ci\u003ePaola Guglielmelli and Alessandro Maria Vannucchi\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e23 Primary Myelofibrosis 275\u003cbr\u003e\u003ci\u003eDouglas Tremblay, Sangeetha Venugopal, John Mascarenhas, and Ruben Mesa\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e24 Hematopoietic Cell Transplantation and Cellular Therapy in Primary and Post ET\/PV Myelofibrosis 287\u003cbr\u003e\u003ci\u003eJerry Luo, Irum Khan, and Damiano Rondelli\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e25 Chronic Myelomonocytic Leukemia 305\u003cbr\u003e\u003ci\u003eMrinal M. Patnaik\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e26 Eosinophilic Myeloproliferative Disorders 315\u003cbr\u003e\u003ci\u003eJason Gotlib\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePart 5 Chronic Lymphocytic and Other Leukemias 331\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e27 Chronic Lymphocytic Leukemia\/Small Lymphocytic Lymphoma 333\u003cbr\u003e\u003ci\u003eJayastu Senapati, Nitin Jain, and Susan O'Brien\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e28 Hematopoietic Cell Transplantation and Cellular Therapy in Chronic Lymphocytic Leukemia 345\u003cbr\u003e\u003ci\u003eAjay Major, Michael R. Bishop, and Peter A. Riedell\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e29 Prolymphocytic Leukemia 357\u003cbr\u003e\u003ci\u003eDima El-Sharkawi and Claire Dearden\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e30 Hairy Cell Leukemia 371\u003cbr\u003e\u003ci\u003eJustin M. Watts and Martin S. Tallman\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePart 6 Hodgkin Lymphoma 385\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e31 Classic Hodgkin Lymphoma 387\u003cbr\u003e\u003ci\u003eChristopher R. D'Angelo, James O. Armitage, and Nancy L. Bartlett\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e32 Nodular Lymphocyte-Predominant Hodgkin Lymphoma 401\u003cbr\u003e\u003ci\u003eDennis A. Eichenauer\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e33 Hematopoietic Cell Transplantation and Cellular Therapy in Hodgkin Lymphoma 408\u003cbr\u003e\u003ci\u003eNarendranath Epperla, Alex F. Herrera, and Matthew Mei\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePart 7 Non-Hodgkin's Lymphomas 417\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e34 Pitfalls in the Diagnosis of Non-Hodgkin's Lymphomas 419\u003cbr\u003e\u003ci\u003eCarmen Barcena and Laurence de Leval\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e35 Follicular Lymphoma 435\u003cbr\u003e\u003ci\u003eDanielle Wallace, Nancy Torres, and Carla Casulo\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e36 Mantle Cell Lymphoma 447\u003cbr\u003e\u003ci\u003eChristina Poh and Stephen D. Smith\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e37 Marginal Zone Lymphoma 455\u003cbr\u003e\u003ci\u003eErin Mulvey, Wayne Tam, and Peter Martin\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e38 Hematopoietic Cell Transplantation and Cellular Therapy in Indolent Non-Hodgkin's Lymphomas 471\u003cbr\u003e\u003ci\u003eKarthik Nath and Craig S. Sauter\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e39 Diffuse Large B Cell Lymphoma 485\u003cbr\u003e\u003ci\u003eAlessia Castellino and Grzegorz S. Nowakowski\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e40 Hematopoietic Cell Transplantation and Cellular Therapy in Diffuse Large B Cell Lymphoma 499\u003cbr\u003e\u003ci\u003eShreya Desai, Syed Maaz Tariq, Arjun Patel, Istvan Redei, and Syed A. Abutalib\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e41 Primary Mediastinal Large B Cell Lymphoma 515\u003cbr\u003e\u003ci\u003eAlessandro Broccoli and Pier Luigi Zinzani\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e42 Double-Hit and Double-Expressor Lymphomas 525\u003cbr\u003e\u003ci\u003eDavid A. Russler-Germain and Brad S. Kahl\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e43 Transformed Lymphoma 539\u003cbr\u003e\u003ci\u003eFrederique St-Pierre and Jane N. Winter\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e44 Burkitt Lymphoma 555\u003cbr\u003e\u003ci\u003eMark Roschewski and Wyndham Wilson\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e45 Primary and Secondary CNS Lymphomas 563\u003cbr\u003e\u003ci\u003eLeon D. Kaulen, Nicholas A. Blondin, Fred H. Hochberg, and Joachim M. Baehring\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e46 HIV-Associated Lymphoma 579\u003cbr\u003e\u003ci\u003eElif Yilmaz and Kieron Dunleavy\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e47 Waldenström's Macroglobulinemia 589\u003cbr\u003e\u003ci\u003eMorie A. Gertz\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e48 Primary Cutaneous Lymphomas 599\u003cbr\u003e\u003ci\u003eNicholas A. Trum, Jasmine Zain, Steven T. Rosen, and Christiane Querfeld\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e49 Mycosis Fungoides and Sézary Syndrome 635\u003cbr\u003e\u003ci\u003eRobert Stuver, Alison Moskowitz, Sarah Noor, and Steven M. Horwitz\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e50 Peripheral T-Cell Lymphoma 647\u003cbr\u003e\u003ci\u003eAvyakta Kallam and James O. Armitage\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePart 8 Plasma Cell Neoplasms and Related Disorders 659\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e51 Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma 661\u003cbr\u003e\u003ci\u003eFrancesco Maura, Dickran Kazandjian, and Ola Landgren\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e52 Risk Stratification Including Measurable Residual Disease in Multiple Myeloma 673\u003cbr\u003e\u003ci\u003eCharalampos Charalampous and Shaji Kumar\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e53 Newly Diagnosed Multiple Myeloma: Transplant Eligible 687\u003cbr\u003e\u003ci\u003eSagar Lonial\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e54 Newly Diagnosed Multiple Myeloma: Transplant Ineligible 699\u003cbr\u003e\u003ci\u003eDaniele Derudas and Claudio Cerchione\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e55 Relapsed\/Refractory Multiple Myeloma 713\u003cbr\u003e\u003ci\u003eNeha Korde and Saad Z. Usmani\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e56 Light-chain (AL) Amyloidosis 727\u003cbr\u003e\u003ci\u003eVaishali Sanchorawala\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e57 Bispecific T Cell Engager and Cell Based Immune Therapy in Multiple Myeloma 739\u003cbr\u003e\u003ci\u003eMeera Mohan, Parameswaran Hari, and Saurabh Chhabra\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePart 9 Special Issues in Neoplastic Hematology and Cellular Therapy 751\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e58 Treatment of Lymphomas During Pregnancy 753\u003cbr\u003e\u003ci\u003eKieron Dunleavy, Emanuele Zucca, and Fedro A. Peccatori\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e59 Complications and Management of CAR T Cell Therapy 767\u003cbr\u003e\u003ci\u003eRadowan A. Elnair and Matthew A. Lunning\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e60 Acute Graft-versus-Host Disease 781\u003cbr\u003e\u003ci\u003eAaron Etra, Uroosa Ibrahim, Jacques Azzi, and John E. Levine\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e61 Chronic Graft-versus-Host Disease 793\u003cbr\u003e\u003ci\u003eAndrew Trunk and Daniel R. Couriel\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003eIndex 809\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e","brand":"My Store","offers":[{"title":"PDF","offer_id":56778120659275,"sku":null,"price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1031\/1204\/8971\/files\/61UV7U9N3WL.jpg?v=1773316419","url":"https:\/\/bookread.io\/products\/cancer-consult-expertise-in-clinical-practice-volume-2-neoplastic-hematology-cellular-therapy","provider":"bookread","version":"1.0","type":"link"}